Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

C–kit proto-oncogene expression in uterine leiomyosarcomas: case series

Naik , V.R., and Hasnan J., (2008) C–kit proto-oncogene expression in uterine leiomyosarcomas: case series. International Medical Journal, 7 (2). pp. 51-54. ISSN 1823-4631

[img]
Preview
PDF (Case Report) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
670Kb

Official URL: http://www.e-imj.com/

Affiliations

Universiti Sains Malaysia, School of Medical Sciences
Universiti Sains Malaysia, School of Medical Sciences

Abstract

Introduction: The proto-oncogene c-kit is the cellular homologue of the oncogene v-kit of HZ4 feline sarcoma virus. It is located on chromosome 4 (4q11-12) in the human genome. Interaction between the c-kit receptor and its ligand, stem cell factor, is essential in the development of tissues. C-kit expression has been identified in a number of different neoplasms like seminoma/dysgerminoma, and gastrointestinal stromal tumors (GIST). Recently it has been reported that c-kit is also present in leiomyosarcomas. Tyrosine kinase inhibitors (TKIs) are a promising new therapy in the treatment of cancer. These agents target cellular proteins like kit and its related homologues decreasing cellular proliferation and survival. TKIs may be helpful in treating leiomyosarcomas expressing c-kit. Materials and Methods: In this study a total of 6 cases diagnosed as leiomyosarcomas at Department of Pathology, Universiti Sains Malaysia, Kubang Kerian, Malaysia, were investigated for reactivity for c-kit using immunohistochemical stain. Stain was considered positive if more than 10 percent of the cells showed membrane or cytoplasmic positivity. Results: Two leiomyosarcomas stained faintly with c-kit and in less than 10 percent of the cells. The other 4 cases showed no staining. The control showed good membrane and cytoplasmic positivity. Conclusion: Uterine leiomyosarcomas did not express c-kit. The reason for this could be that the tumors are inherently c-kit negative. More study using larger number of cases is required to validate these findings and further molecular characterization of these mesenchymal tumors is needed to identify the true nature of these sarcomas.

Item Type:Journal
Keywords:Leiomyosarcoma, Uterus, C-kit protein, Immunohistochemistry.
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:11195

1. Klein WM, Kurman RJ. Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary. Int J Gynecol Pathol 2003; 22:181-4

2. Inoue M, Kyo S, Fujita M, Enomoto T, Kondoh G. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res 1994; 54:3049-53

3. Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, Seto M, Seito T, Sugiura T, Ariyoshi Y, Takahashi T, et al. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol 1993;142:339-46

4. Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res 1992;

52:6139-43.

5. Gibson PC, Cooper K. CD117 (KIT): a diverse protein with selective applications in surgical pathology. Adv Anat Pathol 2002; 9:65-9.

6. Mayerhofer K, Obermair A, Windbichler G, Petru E, Kaider A, Hefler L, Czerwenka K, Leodolter S, Kainz C. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999; 74:196-201.

7. Winter WE 3rd, Seidman JD, Krivak TC, Chauhan S, Carlson JW, Rose GS, Birrer MJ. Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus. Gynecol Oncol 2003; 91:3-8.

8. Chin-Hsiung Hsieh, Hao Lin, Chao-Cheng Huang, Eng-Yen Huang, Shiuh-Young Chang and Chan-Chao ChangChien. Leiomyosarcoma of the uterus: a clinicopathologic study of 21 cases. Acta Obstet Gynecol Scand 2003; 82:74-81

9. Wang L, Felix JC, Lee JL, Tan PY, Tourgeman DE, O’Meara AT, Amezcua CA. The proto-on cogene c-kit is expressed in leiomyosarcomas of the uterus. Gynecol Oncol 2004; 93:718

10. Rushing RS, Shajahan S, Chendil D, Wilder JL, Pulliam J, Lee EY, Ueland FR, van Nagell JR, Ahmed MM, Lele SM. Uterine sarcomas express KIT protein but lack mutation(s) in

exon 11 or 17 of c-KIT. Gynecol Oncol 2003; 91:9-14

11. Leath CA 3rd, Straughn JM Jr, Conner MG, Barnes MN 3rd, Alvarez RD, Partridge EE, Huh WK. Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the

uterus: a case series. J Reprod Med 2004;49:71-5

12. Raspollini MR, Amunni G, Villanucci A, Pinzani P, Simi L, Paglierani M, Taddei GL. C-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment. Clin Cancer Res 2004;10:3500-3

13. Raspollini MR, Paglierani M, Taddei GL, Villanucci A, Amunni G, Taddei A. The protooncogene c-KIT is expressed in

leiomyosarcomas of the uterus. Gynecol Oncol 2003; 90:402-6

Repository Staff Only: item control page
 
 
 
 
 
 
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.